vs
Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and Primoris Services Corp (PRIM). Click either name above to swap in a different company.
Primoris Services Corp is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.2× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 2.8%, a 1.7% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 6.7%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $121.1M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 14.7%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Primoris Services Corporation is a publicly traded specialty construction and infrastructure company based in the United States, with a particular focus on pipelines for natural gas, wastewater and water. As of 2014 it was a Fortune 1000 company.
ONC vs PRIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.9B |
| Net Profit | $66.5M | $51.7M |
| Gross Margin | 90.5% | 9.4% |
| Operating Margin | 12.4% | 4.2% |
| Net Margin | 4.4% | 2.8% |
| Revenue YoY | 32.8% | 6.7% |
| Net Profit YoY | 143.8% | -4.2% |
| EPS (diluted) | $0.05 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.9B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.0B | $1.6B | ||
| Q2 24 | $929.2M | $1.6B | ||
| Q1 24 | $751.7M | $1.4B |
| Q4 25 | $66.5M | $51.7M | ||
| Q3 25 | $124.8M | $94.6M | ||
| Q2 25 | $94.3M | $84.3M | ||
| Q1 25 | $1.3M | $44.2M | ||
| Q4 24 | $-151.9M | $54.0M | ||
| Q3 24 | $-121.3M | $58.4M | ||
| Q2 24 | $-120.4M | $49.5M | ||
| Q1 24 | $-251.2M | $18.9M |
| Q4 25 | 90.5% | 9.4% | ||
| Q3 25 | 86.1% | 10.8% | ||
| Q2 25 | 87.5% | 12.3% | ||
| Q1 25 | 85.2% | 10.4% | ||
| Q4 24 | 85.8% | 10.6% | ||
| Q3 24 | 83.0% | 12.0% | ||
| Q2 24 | 85.1% | 11.9% | ||
| Q1 24 | 83.4% | 9.4% |
| Q4 25 | 12.4% | 4.2% | ||
| Q3 25 | 11.5% | 6.3% | ||
| Q2 25 | 6.7% | 6.7% | ||
| Q1 25 | 1.0% | 4.3% | ||
| Q4 24 | -7.0% | 5.0% | ||
| Q3 24 | -12.0% | 6.0% | ||
| Q2 24 | -11.5% | 5.5% | ||
| Q1 24 | -34.8% | 3.1% |
| Q4 25 | 4.4% | 2.8% | ||
| Q3 25 | 8.8% | 4.3% | ||
| Q2 25 | 7.2% | 4.5% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | -13.5% | 3.1% | ||
| Q3 24 | -12.1% | 3.5% | ||
| Q2 24 | -13.0% | 3.2% | ||
| Q1 24 | -33.4% | 1.3% |
| Q4 25 | $0.05 | $0.94 | ||
| Q3 25 | $0.08 | $1.73 | ||
| Q2 25 | $0.06 | $1.54 | ||
| Q1 25 | $0.00 | $0.81 | ||
| Q4 24 | $-0.10 | $0.98 | ||
| Q3 24 | $-0.09 | $1.07 | ||
| Q2 24 | $-0.09 | $0.91 | ||
| Q1 24 | $-0.19 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $535.5M |
| Total DebtLower is stronger | $836.4M | $469.9M |
| Stockholders' EquityBook value | $4.4B | $1.7B |
| Total Assets | $8.2B | $4.4B |
| Debt / EquityLower = less leverage | 0.19× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $535.5M | ||
| Q3 25 | $4.0B | $431.4M | ||
| Q2 25 | $2.8B | $390.3M | ||
| Q1 25 | $2.5B | $351.6M | ||
| Q4 24 | $2.6B | $455.8M | ||
| Q3 24 | $2.7B | $352.7M | ||
| Q2 24 | $2.6B | $207.4M | ||
| Q1 24 | $2.8B | $177.6M |
| Q4 25 | $836.4M | $469.9M | ||
| Q3 25 | — | $486.0M | ||
| Q2 25 | — | $603.1M | ||
| Q1 25 | — | $612.0M | ||
| Q4 24 | — | $734.8M | ||
| Q3 24 | — | $903.7M | ||
| Q2 24 | — | $933.0M | ||
| Q1 24 | — | $951.7M |
| Q4 25 | $4.4B | $1.7B | ||
| Q3 25 | $4.1B | $1.6B | ||
| Q2 25 | $3.8B | $1.5B | ||
| Q1 25 | $3.5B | $1.4B | ||
| Q4 24 | $3.3B | $1.4B | ||
| Q3 24 | $3.4B | $1.4B | ||
| Q2 24 | $3.4B | $1.3B | ||
| Q1 24 | $3.4B | $1.2B |
| Q4 25 | $8.2B | $4.4B | ||
| Q3 25 | $7.6B | $4.6B | ||
| Q2 25 | $6.3B | $4.5B | ||
| Q1 25 | $5.8B | $4.2B | ||
| Q4 24 | $5.9B | $4.2B | ||
| Q3 24 | $5.8B | $4.2B | ||
| Q2 24 | $5.7B | $4.0B | ||
| Q1 24 | $5.7B | $4.0B |
| Q4 25 | 0.19× | 0.28× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.39× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $417.3M | $142.9M |
| Free Cash FlowOCF − Capex | $379.8M | $121.1M |
| FCF MarginFCF / Revenue | 25.4% | 6.5% |
| Capex IntensityCapex / Revenue | 2.5% | 1.2% |
| Cash ConversionOCF / Net Profit | 6.28× | 2.76× |
| TTM Free Cash FlowTrailing 4 quarters | $941.7M | $340.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $417.3M | $142.9M | ||
| Q3 25 | $402.6M | $182.9M | ||
| Q2 25 | $263.6M | $78.5M | ||
| Q1 25 | $44.1M | $66.2M | ||
| Q4 24 | $75.2M | $298.3M | ||
| Q3 24 | $188.4M | $222.5M | ||
| Q2 24 | $-95.6M | $16.1M | ||
| Q1 24 | $-308.6M | $-28.5M |
| Q4 25 | $379.8M | $121.1M | ||
| Q3 25 | $354.5M | $148.4M | ||
| Q2 25 | $219.8M | $45.3M | ||
| Q1 25 | $-12.3M | $25.6M | ||
| Q4 24 | $-17.3M | $270.0M | ||
| Q3 24 | $54.7M | $158.8M | ||
| Q2 24 | $-205.5M | $-8.1M | ||
| Q1 24 | $-465.1M | $-38.9M |
| Q4 25 | 25.4% | 6.5% | ||
| Q3 25 | 25.1% | 6.8% | ||
| Q2 25 | 16.7% | 2.4% | ||
| Q1 25 | -1.1% | 1.6% | ||
| Q4 24 | -1.5% | 15.5% | ||
| Q3 24 | 5.5% | 9.6% | ||
| Q2 24 | -22.1% | -0.5% | ||
| Q1 24 | -61.9% | -2.8% |
| Q4 25 | 2.5% | 1.2% | ||
| Q3 25 | 3.4% | 1.6% | ||
| Q2 25 | 3.3% | 1.8% | ||
| Q1 25 | 5.0% | 2.5% | ||
| Q4 24 | 8.2% | 1.6% | ||
| Q3 24 | 13.3% | 3.9% | ||
| Q2 24 | 11.8% | 1.5% | ||
| Q1 24 | 20.8% | 0.7% |
| Q4 25 | 6.28× | 2.76× | ||
| Q3 25 | 3.22× | 1.93× | ||
| Q2 25 | 2.79× | 0.93× | ||
| Q1 25 | 34.71× | 1.50× | ||
| Q4 24 | — | 5.53× | ||
| Q3 24 | — | 3.81× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | — | -1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONC
Segment breakdown not available.
PRIM
| Energy Segment | $1.2B | 64% |
| Unit Price Contracts | $473.7M | 25% |
| Cost Reimbursable Contracts | $121.3M | 7% |
| Other | $74.9M | 4% |
